In sufferers who may be vulnerable to intracranial effects of CO2 retention (e.g., those with evidence of greater intracranial tension or brain tumors), therapy may reduce respiratory travel, and resultant CO2 retention can further more enhance intracranial pressure; monitor this kind of patients for indications of sedation and respiratory despair,